Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 3A4 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CYCLOSPORINE 68,304 9,332 13.7% 14,257 3,257 45.2 yrs 56.5%
IMATINIB 43,161 13,761 31.9% 7,264 1,050 55.7 yrs 47.2%
EVEROLIMUS 39,640 8,374 21.1% 11,211 1,311 53.4 yrs 60.0%
DASATINIB 30,019 2,681 8.9% 6,437 669 56.4 yrs 51.9%
TICAGRELOR 22,885 2,951 12.9% 8,579 1,698 65.9 yrs 36.7%
VOXELOTOR 21,940 396 1.8% 7,660 66 33.5 yrs 61.0%
PAZOPANIB 21,208 5,612 26.5% 4,347 572 61.2 yrs 41.2%
CLARITHROMYCIN 18,945 987 5.2% 6,385 1,129 52.9 yrs 67.0%
FLUCONAZOLE 15,157 2,546 16.8% 5,821 1,494 51.5 yrs 55.9%
DILTIAZEM 14,726 4,562 31.0% 6,674 1,762 67.1 yrs 70.8%

Head-to-Head Comparisons

CYCLOSPORINE vs IMATINIB CYCLOSPORINE vs EVEROLIMUS CYCLOSPORINE vs DASATINIB CYCLOSPORINE vs TICAGRELOR IMATINIB vs EVEROLIMUS IMATINIB vs DASATINIB IMATINIB vs TICAGRELOR EVEROLIMUS vs DASATINIB EVEROLIMUS vs TICAGRELOR DASATINIB vs TICAGRELOR
← Back to Cytochrome P450 3A4 Inhibitors [MoA] Class side effects →